Questions: Antibiotic Resistance: Mechanisms and Evolutionary Dynamics

Question 1

A patient takes a full course of antibiotics for a bacterial infection. After treatment, a small population of resistant bacteria remains. Which explanation best accounts for this resistance?

• A. The antibiotic induced mutations in the bacteria, causing them to become resistant during treatment
• B. The antibiotic killed susceptible bacteria while leaving rare pre-existing resistant mutants to survive and proliferate
• C. The bacteria sensed the chemical threat and activated defensive gene expression
• D. Horizontal gene transfer occurred during antibiotic treatment, transferring resistance plasmids

Answer: (B)

Antibiotic resistance is a consequence of natural selection on pre-existing variation, not induction. Any large bacterial population contains rare mutants carrying resistance genes — most acquired through prior spontaneous mutations or horizontal transfer that predates this patient's treatment. The antibiotic kills susceptible cells but does not touch resistant ones; those survivors reproduce and dominate. Option A describes Lamarckian inheritance, which does not apply to bacteria. Option C describes immune-style adaptive responses that bacteria do not possess. Option D is possible but is not the primary explanation for resistance surviving a single course.

Question 2

A hospital laboratory finds that a Klebsiella strain that was fully drug-susceptible last year is now multidrug-resistant, despite never being cultured in the presence of antibiotics. What best explains this transformation?

• A. Rapid spontaneous mutation selected by antibiotic pressure in neighboring wards
• B. The strain adapted its gene expression in response to antibiotic-resistant neighbors
• C. Horizontal gene transfer via conjugation delivered resistance plasmids from resistant bacteria in the same environment
• D. The strain was never truly susceptible — susceptibility testing was in error

Answer: (C)

Horizontal gene transfer (HGT) allows bacteria to acquire resistance without direct antibiotic exposure and without needing to wait for vertical inheritance. A single conjugation event can deliver a plasmid carrying multiple resistance genes from a resistant donor to a susceptible recipient, instantly converting it to multidrug resistance — even across species lines. This is why resistance can spread through a hospital microbiome rapidly and why surveillance of resistance gene flow, not just individual patient isolates, is essential.

Question 3

Antibiotic exposure causes bacteria to mutate and develop resistance to that specific antibiotic.

• T. True
• F. False

Answer: False

This is the most common and consequential misconception about antibiotic resistance. Antibiotics do not cause resistance mutations — they select for resistance genes that already exist in the population. Spontaneous mutations occur at a low background rate during DNA replication regardless of antibiotic exposure; most are neutral or harmful, but a rare one may confer resistance. When an antibiotic is introduced, it kills susceptible cells and allows those rare pre-existing resistant mutants to dominate. Resistance genes have been found in ancient bacterial samples and in soil bacteria that have never encountered clinical antibiotics.

Question 4

Resistance genes can exist in bacterial populations before those bacteria have ever been exposed to clinical antibiotics, because soil bacteria have been waging chemical warfare against each other for billions of years.

• T. True
• F. False

Answer: True

This is the evolutionary reality that makes the 'antibiotics cause resistance' framing so misleading. Antibiotics are often derived from natural compounds (penicillin from Penicillium fungi, streptomycin from Streptomyces bacteria) that microorganisms in the environment have been producing — and defending against — for billions of years. Resistance mechanisms like β-lactamases predate clinical medicine entirely. This is why resistance to a new antibiotic can appear in clinical settings within months of the drug's introduction: resistance genes already exist somewhere in the global microbial gene pool.

Question 5

Why is it clinically important to distinguish between antibiotics 'causing' resistance versus antibiotics 'selecting for' resistance, and what practical difference does this distinction make?

Model answer: If antibiotics caused resistance, exposing bacteria to sub-lethal doses might be harmless since no antibiotic = no resistance. The selection model reveals the opposite: any antibiotic exposure — including incomplete courses or sub-lethal concentrations — creates selective pressure that enriches resistant variants. This means stewardship (using antibiotics only when needed, completing courses, avoiding sub-therapeutic doses) directly reduces resistance evolution. The distinction also explains why resistance exists even in populations that have never received antibiotics and why combination therapy (using multiple drugs) dramatically reduces the probability that any single resistant mutant survives.

The clinical stakes are high. Sub-lethal concentrations are especially dangerous because they select for resistance without fully clearing the infection, giving resistant mutants time to proliferate and transfer their genes. Understanding that resistance pre-exists antibiotic use also explains why resistance to brand-new antibiotics can appear quickly — the genes are already out there — and why environmental antibiotic use (in agriculture, livestock) contributes to clinical resistance even without direct contact.